Guardant Health co-CEO nets shares from RSU vesting
Guardant Health, Inc. director and Co-Chief Executive Officer Helmy Eltoukhy, through the Helmy A. Eltoukhy Revocable Trust, reported routine equity compensation activity involving restricted stock units and related tax withholding.
Rhea-AI Filing Summary
Guardant Health, Inc. director and Co-Chief Executive Officer Helmy Eltoukhy, through the Helmy A. Eltoukhy Revocable Trust, reported routine equity compensation activity involving restricted stock units and related tax withholding.
On June 30 and July 1, 2026, a total of 36,529 restricted stock units were converted into an equal number of shares of common stock at a conversion price of $0.00 per share. To satisfy tax withholding obligations tied to these vestings, 18,514 shares of common stock were retained by the company at prices of $150.03 and $170.77 per share, as noted in the footnotes. These F-code dispositions reflect payment of tax liabilities rather than open-market sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 23,997 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 9,715 | $0.00 | $0.00 |
| Exercise | Common Stock | 23,997 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,715 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 17,086 | $170.77 | $2.92M |
| Exercise | Restricted Stock Units | 2,817 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,817 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,428 | $150.03 | $214K |
Footnotes (5)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on March 17, 2026 that vests in four equal installments on the last day of each calendar quarter, March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
revocable trust financial
derivative security financial
non-derivative financial
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Guardant Health (GH) report for Helmy Eltoukhy?
Were the Guardant Health (GH) transactions open-market buys or sells?
What volume of restricted stock units vested for Guardant Health (GH) co-CEO Helmy Eltoukhy?
What do the Form 4 F and M codes mean in Guardant Health (GH)’s filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.